» Articles » PMID: 17114547

Fine-needle Aspiration Biopsy of Solid Pancreatic Masses: Comparison of CT and Endoscopic Sonography Guidance

Overview
Specialties Oncology
Radiology
Date 2006 Nov 23
PMID 17114547
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Imaging-guided biopsies of solid pancreatic masses are performed with either CT or endoscopic sonography at our institution. We compared test characteristics of fine-needle aspiration biopsies guided using CT with those guided using endoscopic sonography and secondarily evaluated for an effect of mass size.

Materials And Methods: Of 70 solid pancreatic masses, 43 (mean size, 4.4 cm; range, 1.5-10.3 cm) underwent fine-needle (20- to 22-gauge) aspiration biopsy with CT guidance and 27 (mean size, 2.3 cm; range, 1.0-5.0 cm) underwent fine-needle (22-gauge) aspiration biopsy with endoscopic sonography guidance. The diagnostic rate, sensitivity, and negative predictive value (NPV) for each technique were compared using Fisher's exact test before and after stratifying masses by size as small (< or = 3 cm) or large (> 3 cm).

Results: The overall diagnostic rate, sensitivity, and NPV of fine-needle aspiration biopsies guided using CT (97.7%, 94.9%, and 60%, respectively) were not significantly different from those guided using endoscopic sonography (88.9%, 85%, and 57.1%, respectively). Among small masses, the diagnostic rate and sensitivity for biopsies guided using CT (100% and 100%, respectively) were not significantly different from those for biopsies guided using endoscopic sonography (90.9% and 93.8%, respectively). Among large masses, the diagnostic rate and sensitivity (96.6% and 92.3%, respectively) for biopsies guided using CT were not significantly different from those for biopsies guided using endoscopic sonography (83.3% and 50%, respectively).

Conclusion: When biopsying solid pancreatic masses with fine needles, procedures guided with CT and those guided with endoscopic sonography have similar test characteristics regardless of mass size.

Citing Articles

Comparative Assessment of Endoscopic Ultrasound-Guided Biopsies vs. Percutaneous Biopsies of Pancreatic Lesions: A Systematic Review and Meta-Analysis of Diagnostic Performance.

Paramythiotis D, Karlafti E, Tsavdaris D, Arvanitakis K, Protopapas A, Germanidis G J Clin Med. 2024; 13(11).

PMID: 38892819 PMC: 11172871. DOI: 10.3390/jcm13113108.


Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters.

Gaya A, Rohatgi N, Limaye S, Shreenivas A, Ajami R, Akolkar D Cancers (Basel). 2024; 16(7).

PMID: 38611078 PMC: 11010988. DOI: 10.3390/cancers16071400.


Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist's Perspective.

de Jesus V, Riechelmann R Cancer Control. 2023; 30:10732748231173212.

PMID: 37115533 PMC: 10155028. DOI: 10.1177/10732748231173212.


Transabdominal ultrasound-guided pancreatic biopsy: a neglected but safe, effective and inexpensive procedure that needs to be re-juvinalized.

Terracciano F, Marra A, Ippolito A, Bossa F, Sitajolo K, Amoruso A J Ultrasound. 2021; 24(2):175-182.

PMID: 33521888 PMC: 8137799. DOI: 10.1007/s40477-020-00542-y.


Primary pancreatic lymphoma: what we need to know.

Rad N, Khafaf A, Mohammad Alizadeh A J Gastrointest Oncol. 2017; 8(4):749-757.

PMID: 28890827 PMC: 5582029. DOI: 10.21037/jgo.2017.06.03.